Calliditas Therapeutics AB (publ) (CALT) Institutional Ownership $40.00 0.00 (0.00%) As of 04/14/2025 Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Calliditas Therapeutics AB (publ) (NASDAQ:CALT)CurrentInstitutional OwnershipPercentage2.83%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$644.68KNumber ofInstitutional Sellers(last 12 months)0 Get CALT Insider Trade Alerts Want to know when executives and insiders are buying or selling Calliditas Therapeutics AB (publ) stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CALT Institutional Buying and Selling by Quarter Remove Ads Calliditas Therapeutics AB (publ) Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/4/2024Crossmark Global Holdings Inc.16,117$655K0.0%N/A0.054% 2/13/2024Optiver Holding B.V.980$25K0.0%N/A0.003% 5/15/2023Ironwood Investment Management LLC27,795$666K0.4%+5.6%0.093% 5/11/2023Optiver Holding B.V.5,029$120K0.0%-54.9%0.017% 2/10/2023Optiver Holding B.V.11,141$195K0.0%-11.8%0.037% 2/9/2023HBK Sorce Advisory LLC90,000$104K0.0%+100.0%0.302% 1/31/2023Ironwood Investment Management LLC26,309$447K0.3%-8.5%0.088% 11/14/2022Optiver Holding B.V.12,625$191K0.0%+1,304.3%0.043% 11/14/2022HBK Sorce Advisory LLC45,000$50K0.0%N/A0.152% 5/10/2022Ironwood Investment Management LLC28,762$551K0.3%+5.5%0.110% 2/10/2022Ironwood Investment Management LLC27,267$675K0.3%-2.0%0.104% 11/12/2021Ironwood Investment Management LLC27,836$602K0.3%+75.2%0.106% 8/27/2021Endurant Capital Management LP144,393$4.25M1.2%+1.5%0.552% 8/12/2021Advisory Services Network LLC3,369$99K0.0%N/A0.013% 8/11/2021Deutsche Bank AG71,531$2.11M0.0%+1.8%0.286% 7/31/2021NEXT Financial Group Inc4,458$131K0.0%N/A0.018% 5/19/2021Hillhouse Capital Advisors LTD.944,716$26.10M0.3%-9.8%3.783% 5/18/2021Millennium Management LLC15,570$430K0.0%-24.0%0.062% 5/18/2021Tudor Investment Corp Et Al13,782$380K0.0%N/A0.055% 5/18/2021Citadel Advisors LLC9,571$264K0.0%N/A0.038% 5/17/2021Endurant Capital Management LP142,323$3.92M1.0%N/A0.570% (Data available from 1/1/2016 forward)Remove Ads CALT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CALT shares? During the previous two years, the following institutional investors and hedge funds held shares of Calliditas Therapeutics AB (publ) shares: Ironwood Investment Management LLC ($666K), and Crossmark Global Holdings Inc. ($655K), Optiver Holding B.V. ($25K).Learn more on CALT's institutional investors. What percentage of Calliditas Therapeutics AB (publ) stock is owned by institutional investors? 2.83% of Calliditas Therapeutics AB (publ) stock is owned by institutional investors. Learn more on CALT's institutional investor holdings. Which institutional investors have been buying Calliditas Therapeutics AB (publ) stock? The following institutional investors have purchased Calliditas Therapeutics AB (publ) stock in the last 24 months: Crossmark Global Holdings Inc. ($16.12K), Ironwood Investment Management LLC ($1.49K), and Optiver Holding B.V. ($980.00). How much institutional buying is happening at Calliditas Therapeutics AB (publ)? Institutional investors have bought a total of 18,583 shares in the last 24 months. This purchase volume represents approximately $705.53K in transactions. Which Calliditas Therapeutics AB (publ) major shareholders have been selling company stock? The following institutional investors have sold Calliditas Therapeutics AB (publ) stock in the last 24 months: Optiver Holding B.V. ($6.11K). How much institutional selling is happening at Calliditas Therapeutics AB (publ)? Institutional investors have sold a total of 6,112 shares in the last 24 months. This volume of shares sold represents approximately $146.50K in transactions. Related Companies Nuvalent Major Shareholders Grifols Major Shareholders Elanco Animal Health Major Shareholders Verona Pharma Major Shareholders ADMA Biologics Major Shareholders Cytokinetics Major Shareholders Vaxcyte Major Shareholders Rhythm Pharmaceuticals Major Shareholders PTC Therapeutics Major Shareholders Organon & Co. Major Shareholders This page (NASDAQ:CALT) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calliditas Therapeutics AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Calliditas Therapeutics AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.